SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
The study will be conducted in adult patients with Chemotherapy-induced Peripheral Neuropathy (CIPN) that has been persistent for at least 3 months following completion of chemotherapy. A total of 60 patients will be enrolled in equal numbers of a placebo group and two different SON-080 dose groups. Treatment period will be 12 weeks long and patients will be followed-up for an additional 12 weeks.
Epistemonikos ID: 7d000194969ac58ecad0bc4b420f0f5f0ac5abfa
First added on: Oct 02, 2023